Device Cardiovascular

Rbl-Tg

Payments companies reported to CMS as associated with Rbl-Tg. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$146associated payments (2023-2025)
8clinicians with associated payments
1company reporting

By year

2024 $84.16
2025 $61.55

Payments reported as associated with Rbl-Tg, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $44.42
Cardiovascular Disease $35.91
Family $17.63
Internal Medicine $14.64

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Rbl-Tg

These are the largest totals companies reported as associated with Rbl-Tg. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Hoa Nguyen Lubbock, TX $33.11
Kizhake Kurian Palm Coast, FL Cardiovascular Disease $20.78
Amanda Smith Macon, GA Family $17.63
Rafael Rivera Ponce, PR Interventional Cardiology $15.14
Edgardo Bermudez Moreno Ponce, PR Cardiovascular Disease $15.13
Prasanna Manjini Sengodan Moberly, MO Interventional Cardiology $14.64
Spandana Narvaneni Lansing, MI Internal Medicine $14.64
Dennis Morris Greenville, NC Interventional Cardiology $14.64

Prescribed Rbl-Tg?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.